Oppenheimer initiated coverage on Processa Pharmaceuticals with a new price target

8/3/21 4:49:09 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Oppenheimer initiated coverage of Processa Pharmaceuticals with a rating of Outperform and set a new price target of $20.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$PCSA

Date	Price Target	Rating	Analyst
4/25/2024	$8.00	Buy	H.C. Wainwright
8/3/2021	$20.00	Outperform	Oppenheimer
8/2/2021	$20.00	Outperform	Oppenheimer